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Abstract
Background: One of the key pathological features of AD is the formation of insoluble amyloid plaques. The major
constituent of these extracellular plaques is the beta-amyloid peptide (Ab), although Ab is also found to accumulate
intraneuronally in AD. Due to the slowly progressive nature of the disease, it is likely that neurons are exposed to sublethal
concentrations of both intracellular and extracellular Ab for extended periods of time.
Results: In this study, we report that daily exposure to a sublethal concentration of Ab1-40 (1 mM) for six days induces
substantial apoptosis of cortical neurons cultured from Tg2576 mice (which express substantial but sublethal levels of
intracellular Ab). Notably, untreated Tg2576 neurons of similar age did not display any signs of apoptosis, indicating that the
level of intracellular Ab present in these neurons was not the cause of toxicity. Furthermore, wildtype neurons did not
become apoptotic under the same chronic Ab1-40 treatment. We found that this apoptosis was linked to Tg2576 neurons
being unable to maintain K
+ homeostasis following Ab treatment. Furthermore, blocking K
+ efflux protected Tg2576
neurons from Ab-induced neurotoxicity. Interestingly, chronic exposure to 1 mMA b1-40 caused the generation of axonal
swellings in Tg2576 neurons that contained dense concentrations of hyperphosphorylated tau. These were not observed in
wildtype neurons under the same treatment conditions.
Conclusions: Our data suggest that when neurons are chronically exposed to sublethal levels of both intra- and extra-
cellular Ab, this causes a K
+-dependent neurodegeneration that has pathological characteristics similar to AD.
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Introduction
Alzheimer’s disease (AD) is characterised by profound synaptic
loss and neuronal death, and the accumulation of a number of key
pathological hallmarks; senile plaques, dystrophic neurites and
neurofibrillary tangles [1]. The b-amyloid peptide (Ab) is the
principle component of plaques, and is thought to contribute
significantly to the pathogenesis of the disease [2]. However, the
precise mechanisms that underlie the role of Ab in AD are not
clearly understood.
The localisation of Ab is likely to have an important role in
governing its toxic actions upon neurons. In this regard, it is well
known that acute extracellular administration of aggregated forms
of Ab (and in particular oligomers) to cultured neurons is
neurotoxic [3]. This is in accordance with the presence of amyloid
plaques in AD, of which extracellular, aggregated forms of Ab are
the major constituent [4]. However, a growing body of evidence
suggests that intraneuronal localisation of Ab may also play a
significant role in AD. For example, Ab accumulates in processes
and synapses prior to, and with the onset of extracellular Ab
plaque formation [5,6], and in transgenic mice that develop Ab
plaques [7]. There is also some evidence that cognitive impairment
in AD patients does not always correlate to the level of Ab plaque
deposition [8]. Similarly Ab immunisation studies in Tg2576 [9]
or PDAPP [10] transgenic mice reversed memory loss, but had no
impact upon amyloid plaque levels. These studies suggest that the
intraneuronal accumulation of Ab may be important in disease
progression and symptom onset.
Indeed, intracellular Ab appears to increase the susceptibility of
neurons to neurodegeneration. For example, Abdul et al [11]
reported that cortical neurons cultured from APP/PS1 transgenic
mice were more vulnerable to oxidative stress, mitochondrial
dysfunction and apoptosis. Yao and colleagues [12] have
demonstrated that 3xTg-AD mice exhibit increased hydrogen
peroxide production and lipid peroxidation. Furthermore, hippo-
campal neurons cultured from these mice exhibited significantly
decreased mitochondrial respiration and increased glycolosis [12].
Notably, cultured neurons transfected with constructs expressing
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19026APP that contains familial-linked AD mutations that substantially
increase levels of Ab are also susceptible to apoptosis-inducing
treatments [13]. Others have linked intracellular Ab directly to
apoptosis, reporting that transfection of constructs expressing Ab
into neuroblastoma cells resulted in activation of a P53-dependent
apoptotic pathway [14]. A similar outcome has been observed
when synthetic Ab peptides were microinjected into neurons,
which induced cytotoxicity via a p53-Bax apoptotic pathway [15].
Notably, exogenously applied Ab is rapidly internalised by
cultured neurons, where it could subsequently act in a neurotoxic
manner like endogenous Ab. Uptake of Ab by neuronal cells
occurs via the low-density lipoprotein receptor LRP1 [16].
Treatment of PC12 cells [17] or primary neuron cultures [18]
with exogenous Ab leads to accumulation of reactive oxygen
species, and a decrease in redox activity and ATP levels [17].
Treatment with alpha-tocopherol (Vitamin E) can block these Ab-
induced changes in neuronal cells (see reviews by [19,20]).
AD is a progressive disease, in which neurons are likely to be
exposed to both intracellular and extracellular Ab at sublethal
concentrations for extended periods of time. To experimentally
model this situation, we have exposed cultured neurons from
Tg2576 mice (which accumulate substantial amounts of intracel-
lular Ab) to daily treatment with exogenous Ab1-40 for 6 days.
Chronic Ab1-40 treatment induced substantial apoptosis of cortical
Tg2576 neurons but not wildtype neurons, suggesting that both
intra- and extra-cellular Ab are required to induce apoptosis.
Apoptosis was linked to an inability of Tg2576 neurons to
maintain K
+ homeostasis following acute treatment with extracel-
lular Ab1-40. Chronic exposure to 1 mMA b1-40 also caused the
generation of hyperphosphorylated tau-immunoreactive axonal
swellings in Tg2576 but not wildtype neurons. Our data suggest
that chronic exposure to both intra- and extra-cellular Ab induces
neurodegenerative changes that bear similarities to some of the
pathological hallmarks of AD.
Results
Uptake of exogenous Ab by cultured transgenic Tg2576
and wildtype cortical neurons
Mouse cortical neurons (wildtype and Tg2576) were maintained
in culture for seven days in vitro (DIV), at which time they were
treated with 10 mM soluble monomeric Ab1-40. After 24 hours,
neurons were fixed and Ab detected by immunostaining. In
untreated Tg2576 cortical neurons, Ab was distributed within the
cytoplasm and processes, but generally not in the nucleus
(Figure 1A). In untreated wildtype cortical neurons, there was no
Ab detected (results not shown). In wildtype neurons treated with
Ab,A b was detected in a punctate distribution within the
cytoplasm and processes (Figure 1B). When Ab was applied to
Tg2576 neurons, the distribution of Ab resembled both of these
scenarios, with both punctate and non-punctate regions of Ab
immunoreactivity observed within the cytoplasm and nucleus
(Figure 1C). When fluorescently tagged Ab1-40 (10 mM) was
applied to either wildtype or Tg2576 cortical neurons, we did not
observe any difference in neuronal uptake or distrubtion of Ab
(results not shown).
Intraneuronal Ab increases the vulnerability of cortical
neurons to neurotoxicity induced by extracellular Ab
7DIV mouse cortical neurons (wildtype and Tg2576) were
treated with soluble monomeric Ab1-40 (1–10 mM) daily for a
period of six days. Measurement of neuronal viability by an
Alamar Blue assay revealed that while daily treatment with 1 mM
Ab1-40 was not toxic to wildtype cortical neurons at any point in
the six day timecourse, this treatment resulted in a significant
reduction in intracellular metabolism of Tg2576 neuronal cultures
by approximately 30% after six days of continual Ab1-40 treatment
(Figure 2A). 10 mMA b1-40 was mildly neurotoxic to wildtype
neurons, resulting in approximately 20% cell death after seven
days of treatment (Figure 2B). However, Tg2576 neurons were far
more susceptible to Ab1-40 (Figure 2B). The neurotoxic actions of
chronic exposure to Ab1-40 upon Tg2576 cortical neurons were
confirmed in propidium iodide uptake studies (Figure 2C),
whereby only dying cells internalise and incorporate propodium
iodide in the nucleus. These results suggest that the non-toxic
accumulation of intraneuronal Ab in Tg2576 cortical neurons
increases their vulnerability to subsequent neurotoxicity induced
by chronic exposure to normally sublethal (1–10 mM) levels of
extracellular Ab. Notably, in all cases when either wildtype or
Tg2576 neurons were treated with vehicle alone, no change in
viability was observed (results not shown).
To investigate whether chronic exposure to both intra- and
extracellular Ab had initiated an apoptotic pathway of cell death,
immunostaining for activated caspase-3 was performed. Almost no
caspase-3 labelled cells were observed in 14 DIV Tg2576 neuronal
cultures (Figure 3A). However, when 7 DIV Tg2576 neurons were
treated with 1 mMA b1-40 for six consecutive days, caspase-3
immunoreactivity correlated with condensed or fragmented nuclei
in approximately 30% of cells (Figure 3B), and direct counting
found that the number of caspase-3 labelled neurons was
equivalent to the number of neurons that incorporated propidium
iodide (results not shown), indicating that the combination of both
intra- and extraneuronal Ab triggered an apoptotic pathway of
neuronal death.
Treatment with Ab causes K
+ flux-dependent
neurotoxicity in Tg2576 neurons
There are a number of reports suggesting that extracellular Ab
triggers changes in ionic homeostasis of neurons, and that these
changes contribute directly to neurotoxicity. To investigate
whether intracellular Ab alters the ability of neurons to maintain
ionic homeostasis following extracellular Ab treatment, we used a
novel non-invasive microelectrode ion flux (MIFE) measuring
technique. Using the MIFE approach, we directly observed that
Ab treatment triggered rapid efflux of K
+ from wildtype neurons
(Figure 4A), which returned to homeostasis within 10 minutes after
Ab1-40 treatment. However, K
+ flux in Tg2576 neurons treated
with Ab1-40 did not return to homeostasis (Figure 4B). Instead,
transgenic neurons exhibited a continual efflux of potassium for
more than 120 minutes after Ab1-40 treatment (Figure 5A).
Measurement of total K
+ flux over 25 minutes following Ab1-40
treatment revealed that significantly more potassium was extruded
from Tg2576 neurons than wildtype neurons (Figure 4C).
Interestingly, continuous treatment of wildtype neurons for three
days with 1 mMA b1-40 did not alter their ability to maintain K
+
homeostasis following Ab treatment (results not shown).
Concurrently,wealsomeasuredH
+fluxofneuronsinresponseto
Ab1-40 treatment. Wildtype neurons treated with Ab1-40 demon-
strated a rapid influx of H
+, which stabilised within 5 minutes
and remained stable for the entire recording period (Figure 4D).
Tg2576 neurons displayed a similar response to Ab1-40
(Figure 4E). However, from about 10 minutes post-treatment,
Tg2576 neurons underwent a slow gradual influx of H
+ (Figure 4E).
The latter was further increased during the next 120 min post-
treatment with Ab1-40 (Figure 5B). Measurement of total H
+ flux
over 25 minutes after Ab treatment revealed that Ab1-40 induced
significantly greater influx of H
+ into Tg2576 neurons in
comparison to wildtype neurons (Figure 4F).
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early step in apoptosis. To confirm that prolonged extrusion of K
+
is responsible for Ab-induced neurotoxicity in Tg2576 neurons,
cells were pre-treated with the classic K
+ channel blocker 4-
aminopyradine (4-AP) prior to Ab treatment. This resulted in a
significant reduction of Ab-induced neuronal death in Tg2576
neurons (Table 1).
The presence of both intra- and extracellular Ab causes
the formation of axonal swellings in cultured neurons
Immunolabelling of the axonal cytoskeleton (tau) revealed that
there was no discernible difference in axonal morphology between
wildtype (Figure 6A) and Tg2576 cortical neurons (Figure 6B) over
7-14 DIV. Daily treatment of 7DIV wildtype neurons with 1 mM
Ab1-40 over the six day experimental timecourse did not markedly
alter axonal morphology (Figure 6C). However, substantial
changes in tau-labelling were observed in Ab1-40 treated Tg2576
neurons. Treatment of Tg2576 neurons with 1 mMA b1-40 resulted
in a substantial increase in intensity of tau immunostaining after
24 hours (Figure 6D). After two daily treatments of Tg2576
neurons with 1 mMA b1-40, blebbing and axonal fragmentation
was apparent (Figure 6D), which worsened after four continuous
days of Ab1-40 treatment (Figure 6D). Furthermore, after four
consecutive days of 1 mMA b1-40 treatment, a number of axonal
swellings were observed in Tg2576 neuron cultures (Figure 6E),
but never in wildtype neurons treated with 1 mMA b1-40 for the
same period of time (results not shown). These intra-axonal
swellings were highlighted by dense accumulations of the
microtubule-associated protein tau, including dense accumulations
of hyperphosphorylated (AT-8 immunoreactive) tau (Figure 6E).
Discussion
AD is a progressive neurodegenerative disease, in which
neurons are likely to be exposed to sublethal concentrations of
both intracellular and extracellular Ab for extended periods of
time. To experimentally model this situation, Tg2576 neurons
(which accumulate substantial amounts of intracellular Ab) and
wildtype neurons received daily treatment with soluble, mono-
meric Ab for 6 days. While this chronic exposure to Ab did not kill
wildtype neurons, it caused substantial apoptosis of Tg2576
neurons. Further studies revealed that Tg2576 neurons were
unable to maintain K
+ and H
+ homeostasis following Ab
treatment, leading to prolonged extrusion of potassium and influx
of protons into Tg2576 neurons. Furthermore, chronic exposure
to 1 mMA b for six days caused the generation of hyperpho-
sphorylated tau-immunoreactive axonal swellings in Tg2576 but
Figure 1. Uptake of soluble Ab by wildtype and Tg2576 cortical neurons in vitro. Wildtype and Tg2576 cortical neurons were treated with
10 mM of monomeric Ab1-40, and immunostained for Ab after 24 hours. In untreated Tg2576 neurons, Ab was smoothly distributed throughout the
cytoplasm and processes of all neurons (A). When Ab1-40 was applied to wildtype neurons, it was internalised and distributed in a punctate manner
within the cytoplasm and processes (B). Notably, not all wildtype neurons internalised Ab1-40 (B). When Ab1-40 was applied to Tg2576 neurons, both
smooth and punctately distributed Ab was detected within neurons (C). scale bar =25 mm.
doi:10.1371/journal.pone.0019026.g001
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exposure to sublethal levels of both intra- and extra-cellular Ab
induces neurodegenerative changes in cultured neurons that bear
similarities to pathological hallmarks observed in AD. These
changes appear to be driven by an inability of Tg2576 to maintain
normal K
+ homeostasis in response to continual exposure to
extracellular Ab.
The mechanism by which Ab causes neurotoxicity or neuronal
dysfunction remains to be fully resolved. Numerous studies have
used cultured neurons to investigate the neurotoxic actions of Ab,
and can generally be classified into two paradigms; experiments
whereby Ab is applied acutely or chronically to cultured neurons
(testing the effect of extracellular Ab upon neurons), and
experiments using neurons cultured from transgenic AD mice
which express human Ab (to test the effect of intracellular Ab upon
neurons). The former experiments have been particularly
informative, revealing important information regarding the
concentration and biochemical form of extracellular Ab that
exhibits toxicity upon cultured neurons; from such studies it is
proposed that soluble oligomeric forms of Ab at .5 mM
concentrations are the most toxic form of extracellular Ab to
neurons [3]. In a similar manner, experiments using neurons
cultured from transgenic AD mice have reported that intraneu-
ronal Ab increases the vulnerability of neurons to stressful cellular
environments such as excitotoxicity and oxidative stress [11]. In
some cases, the intraneuronal expression of Ab itself can trigger
apoptotis of neurons via a p53-dependent mechanism [21,14]. It is
worth noting that one simplistic manner in which exogenous Ab
may induce neurodegenerative changes in Tg2576 neurons is due
to uptake of Ab via LRP1 [16], which increases intracellular Ab
levels above a threshold level leading to decreased viability and
alterations in tau distribution and phosphorylation. However, two
pieces of evidence argue against this possibility. Firstly, the
distribution of endogenous Ab and internalised Ab in Tg2576 is
quite different, suggesting that these two pools of Ab are not able
to act in the same manner. And secondly, our MIFE studies
demonstrate rapid and direct changes in ionic homeostasis of
Tg2576 neurons triggered by application of exogenous Ab,
indicating that exogenously applied Ab is probably acting in a
different manner to intracellular endogenous Ab.
While the studies discussed above have provided important
information regarding the effect of extracellular and intracellular
Ab upon cultured neurons, it is important to consider that AD is a
progressive condition, in which neurons are likely to be
continuously exposed to sublethal concentrations of both intracel-
lular and extracellular Ab. To more accurately model this
situation, Tg2576 neurons (which accumulate Ab intraneuronally)
were cultured in the presence of extracellular Ab. This
combination of intra- and extracellular Ab induced caspase-3
dependent apoptosis of Tg2576 but not wildtype neurons. To
elucidate the mechanisms underlying this, we used a non-invasive
MIFE approach to observe changes in net ion flux of K
+ and H
+
ions in response to Ab. Using this approach, we were able to
continuously observe net ion flux of K
+ and H
+ for more than
2 hours. We found that Ab treatment of wildtype neurons caused
an immediate efflux of K
+, which gradually returned to
homeostasis within 10 minutes. However, we found that Ab-
treated Tg2576 neurons were unable to maintain K
+ homeostasis,
leading to prolonged leakage of K
+ out of neurons. K
+ efflux from
cells is a key early initiator of apoptosis, as a low potassium
intracellular microenvironment assists apoptosome formation and
the activation of caspases and endonucleases. This suggests that
the prolonged extrusion of K
+ from Ab-treated Tg2576 neurons
was the cause of apoptosis in this study. This was confirmed by
undertaking the same experiments in the presence of the K+
channel blocker 4-AP, which provided significant protection
against Ab-induced toxicity in Tg2576 neurons.
A novel element to the MIFE approach in this application is
that it allows measurement of total flux of K
+ into- or out- of cells,
rather than the flow of K+ through particular channels/
transporters that is observed through patch-clamp recording
(electrogenic transporters) and pharmacological inhibitor studies.
Figure 2. Tg2576 cortical neurons are more vulnerable to soluble Ab-induced neurotoxicity. Wildtype and Tg2576 cortical neurons were
treated daily with 1 mM (A) or 10 mM (B) of monomeric Ab1-40 for 6 days, and neuronal viability (intracellular metabolism as assessed by Alamar Blue
assay) assessed every 24 hours. At 1 mM concentrations, only Tg2576 neurons were vulnerable to Ab1-40, resulting in approximately 30% cell death
after 6 days (A). 10 mMA b1-40 was mildly toxic to wildtype neurons over the experimental timecourse, but killed 40% of Tg2576 neurons after 6 days
(B). The Alamar Blue neurotoxicity assay produced similar results to direct counting of dying cells via propidium iodide uptake following treatment
with 10 mMA b1-40 (C). * - p,0.05, ANOVA. Error bars represent standard error values from at least three replicates per experimental condition. This
graph is representative of the results observed from 4 different experiments.
doi:10.1371/journal.pone.0019026.g002
Figure 3. Soluble Ab triggers caspase-3 expression in Tg2576 cortical neurons. Tg2576 neurons cultured for 14 days in vitro (DIV) showed
no signs of caspase-3 activation (A). However, when 7 DIV Tg2576 neurons were treated with 1 mMA b1-40 daily for 6 days, a substantial number of
neurons were found to express caspase-3 (B).
doi:10.1371/journal.pone.0019026.g003
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demonstrating that the neurotoxicity elicited by soluble Ab upon
neurons involves elevated K
+ efflux, mediated through multiple
pathways including enhanced activity of voltage-gated potassium
channels [22,23] and the Na
+/K
+ ATPase [24,25]. Furthermore,
increasing the extracellular K
+ level to prevent K
+ loss is also able
to block Ab-induced neuronal apoptosis [26]. We now demon-
strate the direct measurement of net K
+ flux of neurons in
response to Ab, and report that simultaneous exposure to both
intra- and extracellular Ab significantly impairs the ability of
neurons to regulate K
+ homeostasis. Given that intracellular
accumulation of Ab within neurons in the AD brain is only
observed later in life, our data provides a potential mechanism that
could explain why neurons in the AD brain become vulnerable to
apoptosis later in life despite being continuously exposed to
extracellular Ab for many years.
While the toxicity of Ab has been extensively studied in cultured
neurons, two considerable limitations of these approaches have
been that they have often involved the use of relatively immature
neuronal phenotypes (cultured for between 1–4 days in vitro), and a
treatment period of up to 24 hours. In this study we have cultured
neurons at relatively high density for seven days in vitro prior to
experimentation. Under these conditions, neuronal cultures
contained dense networks of processes more representative of
mature neurons. Chronic exposure of wildtype neurons to
sublethal concentrations of Ab did not alter axonal morphology
of cultured neurons. However, Tg2576 neurons continuously
treated with Ab displayed substantial axonal pathology, including
increased intensity of tau immunolabelling, axonal fragmentation
and degeneration and the formation of axonal swellings that were
packed with hyperphosphorylated tau. While it is well described
that Ab treatment of cultured neurons can directly cause tau
hyperphosphorylation within 24 hours [27], our study is the first
that we are aware of that demonstrates that Ab can cause the
generation of hyperphosphorylated tau-immunoreactive axonal
swellings in mature neuronal cultures. Notably, these axonal
swellings took four days to develop, suggesting that they represent
a slowly evolving, secondary phase of Ab-induced neurodegener-
ation. These dystrophic axonal manifestations resemble some of
the key neuritic pathologies observed in the AD brain, suggesting
that the prolonged effect of intra- and extracellular Ab exposure
upon neurons is a critical step in the neurodegenerative process
underlying AD.
In summary, we propose that in the AD brain, intraneuronal
accumulation of Ab increases the vulnerability of neurons to
subsequent chronic exposure to soluble Ab. This combined
exposure to intra- and extracellular Ab leads to degenerative
changes in neurons (such as axonal swelling and fragmentation)
and apoptosis through a K
+ efflux mediated mechanism.
Methods
Ethics Statement
All animal experimentation was performed under the guidelines
stipulated by the University of Tasmania Animal Ethics Commit-
tee, which is in accordance with the Australian code of practice for
the care and use of animals for scientific purposes.
Cortical neuron cultures from Tg2576 and wildtype mice
Hemizygous Tg2576 male mice on a hybrid B6SjL background
(Taconic) were crossed with wildtype B6SjLF1 females, and
cortical tissue was removed from individual embryos from the
pregnant wildtype mice (the embryos are either transgenic or
wildtype), and cortical neurons isolated as we have described
previously [28]. Cortical neurons from individual pups were
maintained in Neurobasal medium (Gibco) containing 10% fetal
Figure 4. Soluble Ab induces rapid efflux of K
+ in Tg2576 cortical neurons. Treatment with 1 mMA b1-40 triggered rapid efflux of K
+ from
wildtype neurons (A), which returned to homeostasis within 10 minutes. However, Tg2576 neurons treated with Ab1-40 displayed a continual efflux of
K
+ over the recording period (B). Measurement of total K
+ flux over 25 minutes following Ab1-40 treatment revealed that significantly more potassium
was extruded from Tg2576 neurons than wildtype neurons (C). Ab1-40 treatment caused a rapid influx of H
+ in both wildtype (D) and Tg2576 (E)
neurons, which stabilised within 5 minutes. However, from about 10 minutes post-treatment, Tg2576 neurons underwent a slow gradual influx of H
+
(E). Measurement of total H
+ flux over 25 minutes revealed that Ab1-40 induced significantly greater influx of H
+ into Tg2576 neurons in comparison to
wildtype neurons (F). * - p,0.05, t-test. Error bars represent standard error values.
doi:10.1371/journal.pone.0019026.g004
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culture medium was replaced with serum- and glutamic acid-free
culture medium after 24 hours, followed by half media changes
twice weekly. To test the affect of chronic Ab treatment upon
cortical neurons, 1 mMo r1 0mM of soluble monomeric Ab1-40
was added exogenously to 7DIV cultured neurons daily for 6 days
with assessment of cellular viability conducted each day.
Lyophilised Ab1-40 peptide was purchased from EZBiolab, and
solubilised in sterile MQ water (which served as the vehicle control
for all experiments). The Ab1-40 peptide was used in this study
because in our experience the Ab1-42 peptide induces substantial
acute neurotoxicity at 10 mM concentrations, making this peptide
unsuitable for long-term studies. Note that each day, the entire
culture medium was replaced with fresh media to which Ab1-40
was added. All experiments were performed without knowing the
genotype identity (wildtype or transgenic) of the individual neuron
cultures. We generally obtained cultures from 10 embryos per
pregnant animal, and they were usually split evenly between
transgenic and wildtype. At the conclusion of each experiment,
immunocytochemical detection of Ab (using the 6E10 antibody,
see details below) was used to genotype the cultures and reveal
their identity for data analysis and interpretation. Untreated
neuronal cultures at 14 days in vitro were used for this purpose, and
neurons could be easily distinguished as containing either high- or
low- levels of Ab.
Alamar blue viability assay
Neuronal viability was measured by the degree of cellular
metabolic reduction of Alamar BlueH, as we have reported
Figure 5. Soluble Ab induces prolonged efflux of K
+ in Tg2576 cortical neurons. Treatment with 1 mMA b1-40 triggered rapid efflux of K
+
from Tg2576 neurons (A), which continued over the 120 minutes of recording. Ab1-40 treatment caused a rapid influx of H
+ in Tg2576 neurons (B),
which did not stabilise over the 120 minute recording period.
doi:10.1371/journal.pone.0019026.g005
Table 1. Tg2576 cortical neurons are sensitive to soluble Ab
in a K
+-dependent manner.
Treatment Viability (relative to vehicle)
vehicle 10066.9
1 mMA b 60.165.8*
1 mMA b + 2 mM 4-AP 87.466.0*
#
Tg2576 cortical neurons were treated daily with either vehicle (PBS) or 1 mMo f
monomeric Ab1-40 for 6 days, and neuronal viability assessed 24 hours after the
final treatment. This resulted in a reduction in neuronal viability to
approximately 60% of vehicle controls (* - p,0.01, student’s t-test). However,
when Tg2576 neurons were pre-treated with 2 mM 4-AP for 30 minutes prior to
each Ab1-40 treatment, this significantly reduced the neurotoxic action of
exogenous Ab1-40.
(
# -p ,0.01, student’s t-test).
doi:10.1371/journal.pone.0019026.t001
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nation of the fluorescence of Alamar Blue in culture wells
(excitation 535 nm, emission 595 nm), and was expressed as the
percentage of the signal obtained from the vehicle-treated culture.
Alamar Blue was applied at a 1:10 dilution in culture media for 30
minutes, after which time it was collected and fluorescence
measured on a fluorescent plate reader (Tecan Genios). In
experiments involving repeated measurements of viability over a
consecutive series of days, following Alamar Blue collection fresh
media was applied to the neurons and the viability assay procedure
repeated each day. Alamar Blue is non-toxic, and we have not
observed any decline in neuronal viability when using this
technique on consecutive days for up to one week (results not
shown).
Immunocytochemical labelling of neurons
At the completion of experiments, cells were fixed with 4%
paraformaldehyde for 20 minutes and an antibody diluent
containing 0.03% Triton-X detergent was applied. For immuno-
cytochemistry, rabbit anti-tau (1:5000; DAKO), mouse anti-Ab
(6E10; 1:1000; DAKO) and mouse anti-hyperphosphorylated tau
(AT-8; 1:1000; Chemicon) antibodies were applied, and detected
with appropriate Alexa-Fluor-488 or -594 conjugated secondary
antibodies at a 1:1000 concentration (Molecular Probes).
Non-invasive microelectrode ion flux (MIFE)
measurements in cultured neurons
The theory of MIFE measurements was reviewed recently [31]
and the complete experimental procedure including ion-selective
microelectrode fabrication [32] and neuronal culture preparation,
immobilisation and recording were performed as described
previously [30,33]. Briefly, ion selective microelectrodes were
silanised and filled with commercially available ionophore
cocktails (Fluke catalog no. 60031 and 95297 for for K
+ and H
+,
respectively). Microelectrodes for MIFE measurements were
prepared on a daily basis and calibrated before and after
measurements in a range of K
+ and H
+ concentrations. Cortical
neurons for the MIFE measurements were grown for six days at a
density of 1610
5 cells/well on poly-L-lysine-coated coverslips and
chronically treated with soluble monomeric Ab1-40 as described
above. A cover slip with neural cells was washed in and adapted to
the MIFE artificial CSF (aCSF) for one hour prior to experiments.
The composition of the aCSF was: 150 mM NaCl, 0.5 mM KCl,
0.5 mM CaCl2, 1.5 mM MgCl2, 1.25 mM NaH2PO4,5 m M
Figure 6. Soluble Ab causes disruptions in tau distribution in Tg2576 cortical neurons. Tau immunolabelling of the axonal cytoskeleton
demonstrated that axonal morphology was similar between wildtype (A) and Tg2576 (B) cortical neurons over 7–14 DIV. Six daily 1 mMA b1-40
treatments of 7DIV wildtype neurons had no discernible effect upon axonal morphology (C). However, substantial changes in tau-labelling were
observed in Ab1-40 treated Tg2576 neurons (D); including increased intensity of tau immunostaining after 24 hours, followed by blebbing and axonal
fragmentation which worsened after four days of treatment (D). Furthermore, after four consecutive days of 1 mMA b1-40 treatment a number of
axonal swellings, with dense accumulations of hyperphosphorylated tau, were observed in Tg2576 neuron cultures (E). scale bars =30 mm (A–D),
15 mm (E).
doi:10.1371/journal.pone.0019026.g006
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and positioned ,5 mm above the neuronal monolayer and moved
up and down by a computer-controlled stepper motor providing a
travel range between 5 and 50 mm from the cell surface at a
frequency of 0.1 Hz. After recording steady state flux for ,5 min,
neurons were treated with Aß and data acquired at a rate of 15
samples/sec and later averaged over 8 second intervals. For all ion
flux measurements, the sign convention is ‘influx positive’ for a
cation. The data were analysed using MIFE software with ion
fluxes expressed in nmol m
22 s
21. A total flux was calculated as
area between flux curve over the indicated experimental time-
frame (25 min) and the starting flux value.
Statistical analysis
For each experiment unless otherwise stated, a minimum of four
wells from at least three separate cultures (derived from different
animals), were used for quantification. Statistical analysis was
completed using SPSS 16.0 (SPSS). When data was unequally
distributed, data was transformed so that the residuals were
approximately normally distributed. Statistical significance was
calculated using t-test when only two experimental samples were
compared, and One-Way ANOVA with Tukey’s Post Hoc Test
when multiple samples were compared. All graphical data is
presented as mean 6 SEM, significance p,0.05.
Author Contributions
Conceived and designed the experiments: SR CH EDE LS WRB RSC.
Performed the experiments: SR CH EDE CWB LS RSC. Analyzed the
data: SR CH LS RSC. Contributed reagents/materials/analysis tools:
AKW RSC. Wrote the paper: PAA GJG RSC.
References
1. Selkoe DJ, Podlisny MB (2002) Deciphering the genetic basis of Alzheimer’s
disease. Annual Review of Genomics and Human Genetics 3: 67–99.
2. Glenner GG, Wong CW (1984) Alzheimers-Disease - Initial Report of the
Purification and Characterization of a Novel Cerebrovascular Amyloid Protein.
Biochemical and Biophysical Research Communications 120: 885–890.
3. Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, et al. (2008)
Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide
aggregation: Abeta dimers and trimers correlate with neurotoxicity. J Neurosci
28(46): 11950–8.
4. Mattson MP (2004) Pathways towards and away from Alzheimer’s disease.
Nature 430: 631–639.
5. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, et al. (2004)
Oligomerization of Alzheimer’s beta-amyloid within processes and synapses of
cultured neurons and brain. J Neurosci 24(14): 3592–9.
6. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, et al. (2000) Intraneuronal
Abeta42 accumulation in human brain. Am J Pathol 156(1): 15–20.
7. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al. (2003) Triple-
transgenic model of Alzheimer’s disease with plaques and tangles: intracellular
Abeta and synaptic dysfunction. Neuron 39(3): 409–21.
8. Giannakopoulos P, Herrmann FR, Bussie `re T, Bouras C, Ko ¨vari E, et al. (2003)
Tangle and neuron numbers, but not amyloid load, predict cognitive status in
Alzheimer’s disease. Neurology 60(9): 1495–500.
9. Kotilinek LA, Bacskai B, Westerman M, Kawarabayashi T, Younkin L, et al.
(2002) Reversible memory loss in a mouse transgenic model of Alzheimer’s
disease. J Neurosci 22(15): 6331–5.
10. Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, et al. (2002)
Immunization reverses memory deficits without reducing brain Abeta burden in
Alzheimer’s disease model. Nat Neurosci 5(5): 452–7.
11. Sompol P, Ittarat W, Tangpong J, Chen Y, Doubinskaia I, et al. (2008) A
neuronal model of Alzheimer’s disease: an insight into the mechanisms of
oxidative stress-mediated mitochondrial injury. Neuroscience 153(1): 120–30.
12. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, et al. (2009) Mitochondrial
bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of
Alzheimer’s disease. Proc Natl Acad Sci U S A 106(34): 14670–5.
13. Esposito L, Gan L, Yu GQ, Essrich C, Mucke L (2004) Intracellularly generated
amyloid-beta peptide counteracts the antiapoptotic function of its precursor
protein and primes proapoptotic pathways for activation by other insults in
neuroblastoma cells. J Neurochem 91(6): 1260–74.
14. Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, et al. (2005) Intracellular
Abeta42 activates p53 promoter: a pathway to neurodegeneration in
Alzheimer’s disease. FASEB J 19(2): 255–7.
15. Zhang Y, McLaughlin R, Goodyer C, LeBlanc A (2002) Selective cytotoxicity of
intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary
human neurons. J Cell Biol 156(3): 519–29.
16. Fuentealba RA, Liu Q, Zhang J, Kanekiyo T, Hu X, et al. (2010) Low-density
lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake
and lysosomal trafficking. PLoS One 5(7): e11884.
17. Pereira C, Santos MS, Oliveira C (1999) Involvement of oxidative stress on the
impairment of energy metabolism induced by A beta peptides on PC12 cells:
protection by antioxidants. Neurobiol Dis 6(3): 209–19.
18. Yatin SM, Varadarajan S, Link CD, Butterfield DA (1999) In vitro and in vivo
oxidative stress associated with Alzheimer’s amyloid beta-peptide (1-42).
Neurobiol Aging 20(3): 325–30.
19. Butterfield DA, Castegna A, Drake J, Scapagnini G, Calabrese V (2002) Vitamin
E and neurodegenerative disorders associated with oxidative stress. Nutr
Neurosci 5(4): 229–39.
20. Boothby LA, Doering PL (2005) Vitamin C and vitamin E for Alzheimer’s
disease. Ann Pharmacother 39(12): 2073–80.
21. Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, et al. (2005) Intracellular
Abeta42 activates p53 promoter: a pathway to neurodegeneration in
Alzheimer’s disease. FASEB J 19(2): 255–7.
22. Ramsden M, Plant LD, Webster NJ, Vaughan PF, Henderson Z, et al. (2001)
Differential effects of unaggregated and aggregated amyloid beta protein (1-40)
on K(+) channel currents in primary cultures of rat cerebellar granule and
cortical neurones. J Neurochem 79(3): 699–712.
23. Kerrigan TL, Atkinson L, Peers C, Pearson HA (2008) Modulation of ‘A’-type
K+ current by rodent and human forms of amyloid beta protein. Neuroreport
19(8): 839–43.
24. Bores GM, Smith CP, Wirtz-Brugger F, Giovanni A (1998) Amyloid beta-
peptides inhibit Na+/K+-ATPase: tissue slices versus primary cultures. Brain
Res Bull 46(5): 423–7.
25. Dickey CA, Gordon MN, Wilcock DM, Herber DL, Freeman MJ, et al. (2005)
Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice.
BMC Neurosci 6: 7.
26. Yu SP, Farhangrazi ZS, Ying HS, Yeh CH, Choi DW (1998) Enhancement of
outward potassium current may participate in beta-amyloid peptide-induced
cortical neuronal death. Neurobiol Dis 5(2): 81–8.
27. De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, et al. (2008)
Alzheimer’s disease-type neuronal tau hyperphosphorylation induced by A beta
oligomers. Neurobiol Aging 29(9): 1334–47.
28. King AE, Dickson TC, Blizzard CA, Woodhouse A, Foster SS, et al. (2009)
Neuron-glia interactions underlie ALS-like axonal cytoskeletal pathology.
Neurobiol Aging Epub May 6.
29. To ˜ugu V, Karafin A, Zovo K, Chung RS, Howells C, et al. (2009) Zn(II)- and
Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are
transformed to amyloid fibrils, both spontaneously and under the influence of
metal chelators. J Neurochem 110(6): 1784–95.
30. Chung RS, Howells C, Eaton ED, Shabala L, Zovo K, et al. (2010) The native
copper- and zinc-binding protein metallothionein blocks copper-mediated Abeta
aggregation and toxicity in rat cortical neurons. PLoS One 5(8): e12030.
31. Shabala L, Ross T, McMeekin T, Shabala, S (2006) Non-invasive microelec-
trode ion flux measurements to study adaptive responses of microorganisms to
the environment. FEMS Microbiol Rev 30: 472–486.
32. Shabala L, Ross T, Newman I, McMeekin T, Shabala, S (2001) Measurements
of net fluxes and extracellular changes of H+,C a 2 +,K +, and NH4+ in
Escherichia coli using ion-selective microelectrodes. J Microbiol Methods 46(2):
119–29.
33. Shabala L, Howells C, West AK, Chung RS (2010) Prolonged Abeta treatment
leads to impairment in the ability of primary cortical neurons to maintain K+
and Ca2+ homeostasis. Mol Neurodegener 5: 30.
Ab-Induced Neurodegeneration in Tg2576 nNeurons
PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e19026